Articles tagged with “glp-1-agonists”

Pfizer Metsera Acquisition and GLP-1 Obesity Drug Market

Analyze Pfizer's $10B acquisition of Metsera and the evolving GLP-1 obesity drug market. Learn about competing pipelines, clinical data, and pharma strategy.

50 min read

5/2/2026

glp-1 agonists pfizer metsera acquisition obesity drugs pharmaceutical pipelines novo nordisk eli lilly pharma strategy weight loss medications

Kailera Therapeutics IPO: GLP-1 Obesity Pipeline Analysis

Explore Kailera Therapeutics' $625M IPO and GLP-1 obesity pipeline. This analysis covers clinical data, dual agonists, and the 2026 biotech market reopening.

65 min read

4/20/2026

kailera therapeutics glp-1 agonists obesity pipeline biotech ipo dual agonists clinical trials biopharma finance